Key result
This editorial summarizes recent advances in understanding and treating cardiorenal syndrome, highlighting the roles of biomarkers, mitochondrial dysfunction, and new therapeutic strategies.
This editorial highlights recent advances in understanding the pathophysiology, biomarkers, and potential treatments for cardiorenal syndrome.
No takes yet. Share an insight, caveat, or question.
Calvier et al. (2022) conducted an editorial in Cardiorenal Syndrome. This editorial summarizes recent advances in understanding and treating cardiorenal syndrome, highlighting the roles of biomarkers, mitochondrial dysfunction, and new therapeutic strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: